SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-003230
Filing Date
2020-01-13
Accepted
2020-01-13 07:46:33
Documents
47
Period of Report
2020-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm201615-2_8k.htm   iXBRL 8-K 25766
2 EXHIBIT 99.1 tm201615d2_ex99-1.htm EX-99.1 50207
3 GRAPHIC tm201615d2_ex99-1img001.jpg GRAPHIC 64690
4 GRAPHIC tm201615d2_ex99-1img002.jpg GRAPHIC 165216
5 GRAPHIC tm201615d2_ex99-1img003.jpg GRAPHIC 80580
6 GRAPHIC tm201615d2_ex99-1img004.jpg GRAPHIC 66806
7 GRAPHIC tm201615d2_ex99-1img005.jpg GRAPHIC 53213
8 GRAPHIC tm201615d2_ex99-1img006.jpg GRAPHIC 61605
9 GRAPHIC tm201615d2_ex99-1img007.jpg GRAPHIC 44260
10 GRAPHIC tm201615d2_ex99-1img008.jpg GRAPHIC 40920
11 GRAPHIC tm201615d2_ex99-1img009.jpg GRAPHIC 219474
12 GRAPHIC tm201615d2_ex99-1img010.jpg GRAPHIC 42124
13 GRAPHIC tm201615d2_ex99-1img011.jpg GRAPHIC 66403
14 GRAPHIC tm201615d2_ex99-1img012.jpg GRAPHIC 56916
15 GRAPHIC tm201615d2_ex99-1img013.jpg GRAPHIC 104767
16 GRAPHIC tm201615d2_ex99-1img014.jpg GRAPHIC 110285
17 GRAPHIC tm201615d2_ex99-1img015.jpg GRAPHIC 99991
18 GRAPHIC tm201615d2_ex99-1img016.jpg GRAPHIC 96626
19 GRAPHIC tm201615d2_ex99-1img017.jpg GRAPHIC 81414
20 GRAPHIC tm201615d2_ex99-1img018.jpg GRAPHIC 109271
21 GRAPHIC tm201615d2_ex99-1img019.jpg GRAPHIC 119053
22 GRAPHIC tm201615d2_ex99-1img020.jpg GRAPHIC 20683
23 GRAPHIC tm201615d2_ex99-1img021.jpg GRAPHIC 71370
24 GRAPHIC tm201615d2_ex99-1img022.jpg GRAPHIC 59256
25 GRAPHIC tm201615d2_ex99-1img023.jpg GRAPHIC 33004
26 GRAPHIC tm201615d2_ex99-1img024.jpg GRAPHIC 109282
27 GRAPHIC tm201615d2_ex99-1img025.jpg GRAPHIC 77316
28 GRAPHIC tm201615d2_ex99-1img026.jpg GRAPHIC 51665
29 GRAPHIC tm201615d2_ex99-1img027.jpg GRAPHIC 76892
30 GRAPHIC tm201615d2_ex99-1img028.jpg GRAPHIC 98282
31 GRAPHIC tm201615d2_ex99-1img029.jpg GRAPHIC 95344
32 GRAPHIC tm201615d2_ex99-1img030.jpg GRAPHIC 96815
33 GRAPHIC tm201615d2_ex99-1img031.jpg GRAPHIC 61007
34 GRAPHIC tm201615d2_ex99-1img032.jpg GRAPHIC 25012
35 GRAPHIC tm201615d2_ex99-1img033.jpg GRAPHIC 109984
36 GRAPHIC tm201615d2_ex99-1img034.jpg GRAPHIC 82329
  Complete submission text file 0001104659-20-003230.txt   4053395

Data Files

Seq Description Document Type Size
37 XBRL TAXONOMY EXTENSION SCHEMA egrx-20200113.xsd EX-101.SCH 3183
38 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20200113_lab.xml EX-101.LAB 34591
39 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20200113_pre.xml EX-101.PRE 22708
45 EXTRACTED XBRL INSTANCE DOCUMENT tm201615-2_8k_htm.xml XML 3619
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 20522800
SIC: 2834 Pharmaceutical Preparations